IHS Holding stock hits 52-week high at $6.30

IHS Holding Ltd's stock recently achieved a 52-week high, reflecting a robust 90.41% gain over the past six months, propelled by strong Q1 2025 results that surpassed Wall Street expectations for both adjusted EPS ($0.10 vs. $0.08) and revenue ($439.6M vs. $390.49M), alongside a 36.4% increase in adjusted EBITDA. Despite full-year 2025 revenue guidance falling short of analyst projections, the company reaffirmed its outlook and completed a strategic asset sale of its Rwanda operations for $274.5 million. This operational strength, combined with improving macroeconomic conditions in Nigeria, prompted TD Cowen to raise its price target to $17.00 while maintaining a Buy rating, signaling continued analyst confidence despite currency depreciation challenges.

Analysis

IHS Holding Ltd. (IHS) is demonstrating significant operational and market momentum, evidenced by its stock reaching a 52-week high of $6.30 after a 90.41% gain over the past six months. This performance is underpinned by strong Q1 2025 results that surpassed consensus estimates, with revenue growing 5.2% year-over-year to $439.6 million and adjusted EPS coming in at $0.10 versus an expected $0.08. Notably, adjusted EBITDA surged 36.4% to $252.6 million, expanding the associated margin to 57.5%, which indicates enhanced profitability despite challenges like the depreciation of the Nigerian Naira. The company is also executing on its strategic priorities, completing the sale of its Rwanda operations for $274.5 million at an 8.3x EBITDA multiple to optimize its asset portfolio. However, the outlook presents a mixed signal, as the full-year 2025 revenue guidance of $1.68-1.71 billion fell short of analyst projections, creating some investor disappointment even as management reaffirmed its overall financial guidance. This cautious guidance is contrasted by external optimism, with TD Cowen raising its price target to $17.00, citing improving macroeconomic conditions in Nigeria and successful strategic execution.

Key Decisions for Investors

• Investors should weigh the strong Q1 earnings beat and significant 36.4% growth in adjusted EBITDA against the disappointing full-year revenue guidance, which missed analyst forecasts.
• Monitor the impact of macroeconomic factors, particularly the Nigerian Naira's exchange rate, which management identified as a headwind, and any signs of improvement as cited by TD Cowen.
• Given the stock's 90.41% run-up in six months and InvestingPro's 'fairly valued' assessment, consider whether the positive operational results and strategic asset sales are already priced into the current valuation.